Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma by Kung-Hao Liang, Sung-Fang Chen, Yu-Hua Lin, Yu-De Chu, Yang-Hsiang Lin, Ming-Wei Lai, Chih-Lang Lin, Chau-Ting Yeh

“…In vitro assays showed that HCC cells were resistant to sorafenib if pretreated by tenofovir but not entecavir. Clinical analysis showed that the concomitant use of tenofovir and sorafenib was a previously unrecognized predictive factor for unfavorable overall survival (hazard ratio = 2.060, 95% confidence interval = [1.256, 3.381], <i>p</i> = 0.004) in a cohort of 181 hepatitis-B-related, sorafenib-treated HCC patients (concomitant tenofovir versus entecavir treatment; <i>p</i> = 0.003). …”
Get full text

Histomorphometric changes in testis following administration of tenofovir nanoparticles in an animal model by Edwin Coleridge Naidu, Samuel Oluwaseun Olojede, Sodiq Kolawole Lawal, Onyemaechi Okpara Azu

Subjects: “…Tenofovir nanoparticles…”
Get full text

Safety of atazanavir/ritonavir with tenofovir disoproxil fumarate in HIV-infected adolescents by T. Bunupuradah, C. Techasaensiri, S. Keadpudsa, A. Srimuan, T. Sahakijpicharn, C. Sriheara, N. Thammajaruk, W. Prasitsuebsai, J. Ananworanich, T. Puthanakit

Get full text

Fabrication of PEGylated Chitosan Nanoparticles Containing Tenofovir Alafenamide: Synthesis and Characterization by Muhammad Zaman, Muhammad Hammad Butt, Waqar Siddique, Muhammad Omer Iqbal, Naveed Nisar, Asma Mumtaz, Hafiza Yusra Nazeer, Abdulrahman Alshammari, Muhammad Shahid Riaz

Subjects: “…tenofovir alafenamide…”
Get full text

Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates by Hannes Lengauer, Damjan Makuc, Damjan Šterk, Franc Perdih, Arthur Pichler, Tina Trdan Lušin, Janez Plavec, Zdenko Časar

Subjects: Get full text

Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV by Milena M McLaughlin, Aimee J Guerrero, Andrew Merker

“…A review of literature published regarding non-tenofovir antiretroviral agents causing renal adverse effects was conducted. …”
Get full text

Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV by Sara Iannuzzi, Max von Kleist

“…The combination of the two nucleoside reverse transcriptase inhibitors (NRTI) tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is used in most highly active antiretroviral therapies for treatment of HIV-1 infection, as well as in pre-exposure prophylaxis against HIV acquisition. …”
Get full text

Differential binding of tenofovir and adefovir to reverse transcriptase of hepatitis B virus. by Formijn J van Hemert, Ben Berkhout, Hans L Zaaijer

“…(R)-Tenofovir (and not (S)-tenofovir) binds significantly better to HBV-RT than adefovir. …”
Get full text

One-year efficacy of tenofovir alafenamide in patients with chronic hepatitis B by Yi-Cheng Chen, MD, Chao-Wei Hsu, MD, Rong-Nan Chien, MD, Dar-In Tai, MD

“…Non-inferior antiviral efficacy and better renal safety have been reported in chronic hepatitis B patients with tenofovir alafenamide (TAF) treatment. The experience in real-world clinical practice is limited. …”
Get full text

Evaluation of genotoxic activity of tenofovir disoproxil fumarate in human peripheral lymphocytes by Ahmet Kayraldız, Kübra Kurt, Lale Dönbak

Subjects: Get full text

Tenofovir Activating Kinases May Impact the Outcome of HIV Treatment and Prevention by Dimitri Topalis, Robert Snoeck, Graciela Andrei

Subjects: “…Tenofovir activation…”
Get full text

The Effect of Tenofovir Treatment on Renal Function in Chronic Hepatitis B Patients by Yusuf Kayar, Ramazan Dertli, Mehmet Agin, Neslihan Sürmeli, Şevki Konür, Adnan Özkahraman, Nur Düzen Oflas, Mehmet Ali Bilgili

“…However, it is recommended that individuals with chronic HBV who have risk factors such as basal renal dysfunction and comorbidity accompany renal function closely during the Tenofovir treatment.…”
Get full text

Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice by Canetti D, Galli L, Lolatto R, Nozza S, Spagnuolo V, Muccini C, Trentacapilli B, Bruzzesi E, Ranzenigo M, Chiurlo M, Castagna A, Gianotti N

“…Diana Canetti,1 Laura Galli,1 Riccardo Lolatto,1 Silvia Nozza,2 Vincenzo Spagnuolo,1 Camilla Muccini,1 Benedetta Trentacapilli,2 Elena Bruzzesi,2 Martina Ranzenigo,2 Matteo Chiurlo,2 Antonella Castagna,1,2 Nicola Gianotti1 1Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy; 2Infectious Diseases Unit, Vita Salute San Raffaele University, Milan, ItalyCorrespondence: Diana Canetti, Infectious Diseases Unit San Raffaele Scientific Institute, Via Stamira D’Ancona 20, Milano, 20127, Italy, Tel +390226432461, Fax +390226437943, Email canetti.diana@hsr.itObjective: Analysis of bictegravir/emtricitabine/tenofovir alafenamide (BFTAF) efficacy and safety in virologically suppressed people living with HIV (PLWH) in clinical practice.Patients and methods: The retrospective cohort study, which included adult treatment-experienced and virologically suppressed PLWH, switched to BFTAF from June 2019 to June 2021. …”
Get full text

Synergistic anti-HIV-1 activity of griffithsin with tenofovir, maraviroc and enfuvirtide by Schols Dominique, Palmer Kenneth E, Férir Geoffrey

Development and evaluation of mucoadhesive bigel containing tenofovir and maraviroc for HIV prophylaxis by Margaret O. Ilomuanya, Ayotunde T. Hameedat, Edidiong N Akang, Sabdat O. Ekama, Boladale O. Silva, Alani S Akanmu

Subjects: “…Tenofovir…”
Get full text

Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort by Chua Arlene C, Llorin Ryan M, Lai Kelvin, Cavailler Philippe, Law Hwa

Subjects: “…Tenofovir…”
Get full text

Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review by Jing Zeng, Peng Ye, Dong Wei, Lan Li, Wanxia Ma

Subjects: “…tenofovir disoproxil fumarate…”
Get full text

The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis by Chris Kenyon, Nicci Wearne, Rosie Burton, Graeme Meintjes

Get full text

Hypophosphataemia in HIV-positive patients taking non-tenofovir-containing antiretrovirals by Wainwright, E, Dorrell, L, Sherrard, J, Shine, B

Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study by Mahoko Ikeda, Yoshitaka Wakabayashi, Koh Okamoto, Shintaro Yanagimoto, Shu Okugawa, Kyoji Moriya

Subjects: Get full text